Minimal Impact of the COVID‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study

OBJECTIVE: The impact of the COVID‐19 pandemic on patients with inflammatory rheumatic diseases, such as ankylosing spondylitis (AS), has been variable. Here, we assess disease activity and health‐related quality of life (HRQoL) through the pandemic in patients with AS. METHODS: In the open‐label ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Philip C., Machado, Pedro M., Haroon, Nigil, Gensler, Lianne S., Reveille, John D., Taieb, Vanessa, Vaux, Thomas, Fleurinck, Carmen, Oortgiesen, Marga, de Peyrecave, Natasha, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349833/
https://www.ncbi.nlm.nih.gov/pubmed/35833532
http://dx.doi.org/10.1002/acr2.11486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349833/
https://www.ncbi.nlm.nih.gov/pubmed/35833532
http://dx.doi.org/10.1002/acr2.11486

Ejemplares similares